Lv6
2018 积分 2024-08-12 加入
STK19: a new target for NRAS-driven cancer
1天前
待确认
Trabectedin Mechanism of Action: What’s New?
1天前
已关闭
STK19: a new target for NRAS-driven cancer
1天前
待确认
First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of DS‐7011a, an Anti‐TLR7 Antagonistic Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
1天前
待确认
Safety, Pharmacokinetics, Biomarker Response, and Efficacy of E6742, a Dual Antagonist of Toll-Like Receptors 7 and 8, in a First-in-Patient, Randomized, Double-Blind, Phase 1/2 Study in Systemic Lupus Erythematosus
2天前
已完结
Regulation of PCNA–protein interactions for genome stability
2天前
已完结
SnapShot: Targeted protein degradation
3天前
已完结
Cdk5: a multifaceted kinase in neurodegenerative diseases
3天前
已完结
Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders
3天前
已完结
Aggregate-selective removal of pathological tau by clustering-activated degraders
3天前
已完结
皖公网安备34019202002308
